Ethyl Icosapentate and Physical Activity in Treating Fatigue in Patients With Advanced Cancer
Status:
Terminated
Trial end date:
2020-11-24
Target enrollment:
Participant gender:
Summary
This randomized phase II trial studies how well ethyl icosapentate and physical activity work
in treating fatigue in patients with cancer that has spread from where it started to other
places in the body. Ethyl icosapentate and physical activity may provide more robust and
clinically effective improvement of cancer related fatigue, which may facilitate patients
continuing cancer therapy since it would be tolerated and effective in controlling disease.